IVIG/Rituximab vs Rituximab in Kidney Transplant With de Novo Donor-specific Antibodies

NCT04033276 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplant

Interventions

DRUG: Rituximab
DRUG: intravenous immune globulin

Sponsor

Seoul National University Hospital

Collaborators

[object Object]
[object Object]